Effect of MD1003 in Spinal Progressive Multiple Sclerosis
Clinical trial NCT02220933 · UNKNOWN
Trial details
- NCT number
- NCT02220933
- Sponsor
- MedDay Pharmaceuticals SA
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-10-01
- Primary completion
- 2016-01-01
- Enrollment
- 144
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.